Request Demo
Last update 09 Dec 2025
24 valent pneumococcal conjugate vaccine(Shanghai Fosun Pharmaceutical)
Last update 09 Dec 2025
Overview
Basic Info
Drug Type Prophylactic vaccine, Multivalent vaccine, Conjugated vaccine |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with 24 valent pneumococcal conjugate vaccine(Shanghai Fosun Pharmaceutical)CTR20251975
评价24价肺炎球菌多糖结合疫苗接种于2月龄（最小满6周龄）和7月龄及以上健康人群中安全性的I期临床试验
[Translation] Phase I clinical trial to evaluate the safety of 24-valent pneumococcal polysaccharide conjugate vaccine in healthy people aged 2 months (minimum 6 weeks) and 7 months and above
100 Clinical Results associated with 24 valent pneumococcal conjugate vaccine(Shanghai Fosun Pharmaceutical)
Login to view more data
100 Translational Medicine associated with 24 valent pneumococcal conjugate vaccine(Shanghai Fosun Pharmaceutical)
Login to view more data
100 Patents (Medical) associated with 24 valent pneumococcal conjugate vaccine(Shanghai Fosun Pharmaceutical)
Login to view more data
100 Deals associated with 24 valent pneumococcal conjugate vaccine(Shanghai Fosun Pharmaceutical)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pneumococcal Infections | Phase 1 | China | 24 May 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free